Citation

RM Hoffman, MG Warshaw, KR Amico, J Pilotto, G Masheto, J Achalapong, E Machado, K Chokephaibulkit, G Duarte, E Joao, KK Graham, KM Knapp, AM Stek, GB Scott, A Coletti, AJ Loftis, N Chakhtoura, JS Currier, PROMISE 1077HS Team. Predictors of Viremia in Postpartum Women on Antiretroviral Therapy. Journal of Acquired Immune Deficiency Syndromes. 2020. 83: 72-80. PMID: 31651545

Citation

C Onyango-Makumbi, AH Owora, RS Mwiru, A Mwatha, AM Young, D Moodley, HM Coovadia, L Staranix-Chibanda, K Manji, Y Maldonado, P Richardson, P Andrew, K George, W Fawzi, MG Fowler. Extended Prophylaxis With Nevirapine Does Not Affect Growth in HIV-Exposed Infants.. Journal of Acquired Immune Deficiency Syndromes. 2019. 82: 377-385. PMID: 31567725

Citation

DF Clarke, M Mirochnick, EP Acosta, E Capparelli, A Chain, H Teppler, B Smith, J Lommerse, IMPAACT P1110 Study Team. Use of Modeling and Simulations to Determine Raltegravir Dosing in Neonates: A Model for Safely and Efficiently Determining Appropriate Neonatal Dosing Regimens: IMPAACT P1110.. Journal of Acquired Immune Deficiency Syndromes. 2019. 82: 392-398. PMID: 31658182

Citation

KK Venkatesh, M Farhad, T Fenton, D Moodley, S Naik, C Nakabiito, L Fairlie, MG Fowler, JSA Stringer, BH Chi. Association between HIV antiretroviral therapy and preterm birth based on antenatal ultrasound gestational age determination: a comparative analysis.. AIDS. 2019. 33: 2403-2413. PMID: 31764105

Citation

T Meyers, P Samson, EP Acosta, J Moye, E Townley, S Bradford, L Marillo, K Denson, L Hovind, T Sise, H Teppler, SR Mathiba, A Hesseling, MF Cotton, P Krogstad, IMPAACT P1101 Team. Pharmacokinetics and safety of a raltegravir-containing regimen in HIV-infected children aged 2-12 years on rifampicin for tuberculosis. AIDS. 2019. 15: 2197-2203. PMID: 31689263

Citation

CN Le, P Britto, SS Brummel, RM Hoffman, JZ Li, PM Flynn, TE Taha, A Coletti, MG Fowler, RJ Bosch, RT Gandhi, KL Klingman, JA McIntyre, JS Currier. Time to viral rebound and safety after antiretroviral treatment interruption in postpartum women compared with men.. AIDS. 2019. 15: 2149-2156. PMID: 31373919

Citation

E Hompe, D Jacobson, J Eudailey, K Butler, W Edwards, J Pollara, S Brummel, G Fouda, L Chinula, M Kamanga, A Kinikar, D Moodley, M Owor, MG Fowler, S Permar. Maternal humoral immune responses do not predict postnatal HIV-1 transmission risk in antiretroviral-treated mothers from the IMPAACT PROMISE study. mSphere. 2019. 4: e00716-19. PMID: 31645430

Citation

Amita Gupta, Grace Montepiedra, Lisa Aaron, Gerhard Theron , Katie McCarthy , Sarah Bradford , Tsungai Chipato, Tichaona Vhembo, Lynda Stranix-Chibanda, Carolyne Onyango-Makumb, Gaerolwe R Masheto , Avy Violari, Blandina T Mmbaga, Linda Aurpibul, Ramesh Bhosale, Vidya Mave , V Rouzier, A Hesseling, K Shin, B Zimmer, D Costello, TR Sterling, N Chakhtoura, P Jean-Philippe, A Weinberg, P1078 TB APPRISE Study Team. Isoniazid Preventive Therapy in HIV-Infected Pregnant and Postpartum Women. New England Journal of Medicine. 2019. 381: 1333-1346. PMID: 31577875

Citation

M McManus, J Henderson, A Gautam, R Brody, ER Weiss, D Persaud, E Mick, K Lazuriaga, PACTG 356 Investigators. Quantitative Human Immunodeficiency Virus (HIV)-1 Antibodies Correlate With Plasma HIV-1 RNA and Cell-associated DNA Levels in Children on Antiretroviral Therapy.. Clinical Infectious Diseases. 2019. PMID: 30668843

Citation

L Stranix-Chibanda, S Brummel, J Pilotto, M Mutambanengwe, V Chanaiwa, T Mhembere, M Kamateeka, J Aizire, G Masheto, R Chamanga, M Maluwa, S Hanley, E Joao, G Theron, N Nevrekar, M Nyati, B Santos, L Aurpibul, M Mubiana-Mbewe, R Oliveira, T Anekthananon, P Mlay, K Angelidou, C Tierney, L Ziemba, A Coletti, K McCarthy, M Basar, N Chakhtoura, R Browning, J Currier, MG Fowler, P Flynn for the PROMISE study team. Slow acceptance of universal antiretroviral therapy (ART) among mothers enrolled in IMPAACT PROMISE Studies across the globe. AIDS and Behavior. 2019. 23: 2522-2531. PMID: 31399793